Targeted disruption of Nemo-like kinase inhibits tumor cell growth by simultaneous suppression of cyclin D1 and CDK2 in human hepatocellular carcinoma
Version of Record online: 26 MAR 2010
Copyright © 2010 Wiley-Liss, Inc.
Journal of Cellular Biochemistry
Volume 110, Issue 3, pages 687–696, 1 June 2010
How to Cite
Jung, K. H., Kim, J. K., Noh, J. H., Eun, J. W., Bae, H. J., Xie, H. J., Ahn, Y. M., Park, W. S., Lee, J. Y. and Nam, S. W. (2010), Targeted disruption of Nemo-like kinase inhibits tumor cell growth by simultaneous suppression of cyclin D1 and CDK2 in human hepatocellular carcinoma. J. Cell. Biochem., 110: 687–696. doi: 10.1002/jcb.22579
- Issue online: 20 MAY 2010
- Version of Record online: 26 MAR 2010
- Manuscript Accepted: 12 FEB 2010
- Manuscript Received: 2 AUG 2009
- Korea Healthcare technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea. Grant Number: A084930
- Korean Science & Engineering Foundation
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!